S
Zodix
Study
Academic Library
Search
Shelves
Open access
Sign in
Search or jump to…
⌘K
Sory Traoré · Study
Home
/
Author
Sory Traoré
2 works
· latest 2019
· 1 institutions
cluster: provisional
ORCID 0000-0002-1479-2737
Follow
Suggest an ORCID correction
h-index
2
i10
2
Citations
179
Works here
2
18
19
Most cited in this library
Cost-effectiveness of pembrolizumab in combination with chemotherapy in the 1st line treatment of non-squamous NSCLC in the US
2018 · 100 citations
Cost-effectiveness of pembrolizumab in combination with chemotherapy versus chemotherapy and pembrolizumab monotherapy in the first-line treatment of squamous non-small-cell lung cancer in the US
2019 · 79 citations
Works
2 shown
Cost-effectiveness of pembrolizumab in combination with chemotherapy versus chemotherapy and pembrolizumab monotherapy in the first-line treatment of squamous non-small-cell lung cancer in the US
Current Medical Research and Opinion
·
2019
·
7 authors
79
citations
Cost-effectiveness of pembrolizumab in combination with chemotherapy in the 1st line treatment of non-squamous NSCLC in the US
Journal of Medical Economics
·
2018
·
6 authors
·
Open access
100
citations